503 related articles for article (PubMed ID: 26752261)
21. Controlled release of antigen and Toll-like receptor ligands from PLGA nanoparticles enhances immunogenicity.
Cruz LJ; Tacken PJ; Eich C; Rueda F; Torensma R; Figdor CG
Nanomedicine (Lond); 2017 Mar; 12(5):491-510. PubMed ID: 28181470
[TBL] [Abstract][Full Text] [Related]
22. Polymer nanoparticles for enhanced immune response: combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells.
Heo MB; Cho MY; Lim YT
Acta Biomater; 2014 May; 10(5):2169-76. PubMed ID: 24394635
[TBL] [Abstract][Full Text] [Related]
23. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology.
San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS
Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572
[TBL] [Abstract][Full Text] [Related]
24. Extending antigen release from particulate vaccines results in enhanced antitumor immune response.
Kapadia CH; Tian S; Perry JL; Sailer D; Christopher Luft J; DeSimone JM
J Control Release; 2018 Jan; 269():393-404. PubMed ID: 29146244
[TBL] [Abstract][Full Text] [Related]
25. Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity.
Pawar D; Mangal S; Goswami R; Jaganathan KS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):550-9. PubMed ID: 23831265
[TBL] [Abstract][Full Text] [Related]
26. Immune system targeting by biodegradable nanoparticles for cancer vaccines.
Silva JM; Videira M; Gaspar R; Préat V; Florindo HF
J Control Release; 2013 Jun; 168(2):179-99. PubMed ID: 23524187
[TBL] [Abstract][Full Text] [Related]
27. Enhancing immunogenicity to PLGA microparticulate systems by incorporation of alginate and RGD-modified alginate.
Mata E; Igartua M; Patarroyo ME; Pedraz JL; Hernández RM
Eur J Pharm Sci; 2011 Sep; 44(1-2):32-40. PubMed ID: 21699977
[TBL] [Abstract][Full Text] [Related]
28. PLGA/PLA micro- and nanoparticle formulations serve as antigen depots and induce elevated humoral responses after immunization of Atlantic salmon (Salmo salar L.).
Fredriksen BN; Grip J
Vaccine; 2012 Jan; 30(3):656-67. PubMed ID: 22100638
[TBL] [Abstract][Full Text] [Related]
29. Microencapsulation of inorganic nanocrystals into PLGA microsphere vaccines enables their intracellular localization in dendritic cells by electron and fluorescence microscopy.
Schliehe C; Schliehe C; Thiry M; Tromsdorf UI; Hentschel J; Weller H; Groettrup M
J Control Release; 2011 May; 151(3):278-85. PubMed ID: 21223984
[TBL] [Abstract][Full Text] [Related]
30. Surface-functionalized, pH-responsive poly(lactic-co-glycolic acid)-based microparticles for intranasal vaccine delivery: Effect of surface modification with chitosan and mannan.
Li Z; Xiong F; He J; Dai X; Wang G
Eur J Pharm Biopharm; 2016 Dec; 109():24-34. PubMed ID: 27569030
[TBL] [Abstract][Full Text] [Related]
31. Harnessing Dendritic Cells for Poly (D,L-lactide-
Koerner J; Horvath D; Groettrup M
Front Immunol; 2019; 10():707. PubMed ID: 31024545
[TBL] [Abstract][Full Text] [Related]
32. Toward a Single-Dose Vaccination Strategy with Self-Encapsulating PLGA Microspheres.
Bailey BA; Ochyl LJ; Schwendeman SP; Moon JJ
Adv Healthc Mater; 2017 Jun; 6(12):. PubMed ID: 28371568
[TBL] [Abstract][Full Text] [Related]
33. Antigen delivery via hydrophilic PEG-b-PAGE-b-PLGA nanoparticles boosts vaccination induced T cell immunity.
Rietscher R; Schröder M; Janke J; Czaplewska J; Gottschaldt M; Scherließ R; Hanefeld A; Schubert US; Schneider M; Knolle PA; Lehr CM
Eur J Pharm Biopharm; 2016 May; 102():20-31. PubMed ID: 26940132
[TBL] [Abstract][Full Text] [Related]
34. Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells.
Elamanchili P; Diwan M; Cao M; Samuel J
Vaccine; 2004 Jun; 22(19):2406-12. PubMed ID: 15193402
[TBL] [Abstract][Full Text] [Related]
35. Induction of adaptive immune response by self-aggregating peptides.
Zepeda-Cervantes J; Vaca L
Expert Rev Vaccines; 2018 Aug; 17(8):723-738. PubMed ID: 30074424
[TBL] [Abstract][Full Text] [Related]
36. Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro.
Cruz LJ; Tacken PJ; Fokkink R; Joosten B; Stuart MC; Albericio F; Torensma R; Figdor CG
J Control Release; 2010 Jun; 144(2):118-26. PubMed ID: 20156497
[TBL] [Abstract][Full Text] [Related]
37. Lipid core peptide/poly(lactic-co-glycolic acid) as a highly potent intranasal vaccine delivery system against Group A streptococcus.
Marasini N; Khalil ZG; Giddam AK; Ghaffar KA; Hussein WM; Capon RJ; Batzloff MR; Good MF; Skwarczynski M; Toth I
Int J Pharm; 2016 Nov; 513(1-2):410-420. PubMed ID: 27659862
[TBL] [Abstract][Full Text] [Related]
38. Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles.
Shen H; Ackerman AL; Cody V; Giodini A; Hinson ER; Cresswell P; Edelson RL; Saltzman WM; Hanlon DJ
Immunology; 2006 Jan; 117(1):78-88. PubMed ID: 16423043
[TBL] [Abstract][Full Text] [Related]
39. A high-throughput microparticle microarray platform for dendritic cell-targeting vaccines.
Acharya AP; Clare-Salzler MJ; Keselowsky BG
Biomaterials; 2009 Sep; 30(25):4168-77. PubMed ID: 19477505
[TBL] [Abstract][Full Text] [Related]
40. Immune responses to vaccines involving a combined antigen-nanoparticle mixture and nanoparticle-encapsulated antigen formulation.
Zhang W; Wang L; Liu Y; Chen X; Liu Q; Jia J; Yang T; Qiu S; Ma G
Biomaterials; 2014 Jul; 35(23):6086-97. PubMed ID: 24780166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]